Friday, December 31, 2021 7:01:55 PM
And yet, those same people call us skeptics crazy! They honestly think all of us these things are somehow going to magically materialize into approval when history shows in reality that thinking just one of these things will happen is completely nuts. These things don't happen, period. You can't run a trial for 15 years and then change the endpoints right when you lock the data. You can't substitute fake data for the trial's control arm. What's worse is the company has known for six years that these attempts to shift the rules to benefit the trial data are way beyond a long shot. It's obvious in the fact that none of the official trial record has been updated in years. It's obvious that the statements they have made, and the timelines they have given, have been lies. They've known that in any honest evaluation of the situation this trial would have been deemed a failure in 2015 if not before.
But the longs tell us that it's the skeptics who are intentionally trying to sink this stock and company by peddling lies and false information. These things I have mentioned above are not lies or misinformation. They are facts, and any honest reading would HAVE TO acknowledge that the odds of the company pulling this crap off are one in a million. Maybe a couple of the skeptics have an ulterior agenda - probably do. But I have no agenda beyond getting to the truth - and the sooner the better. I'm just a small-time shareholder who can afford to stick this out, who was once a loud pumper for the company and its management, but became completely disillusioned with the bullshit a few years ago.
You are welcome to continue believing that some crazy miracle is still going to happen, but eventually you, too, are going to come to understand that what this company has done, and is doing now, to shareholders is flat-out wrong. Welcome to 2022 people! Did you think in early 2020 that you would have trial data that year? Did you think in 2021 you would have trial data in 2021? And now you think you are going to get it in 2022? And you call us crazy? Get real. Seriously, get real!
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM